20 May 2020 We're delighted to announce that we have been awarded £50,000 from Innovate UK to develop an app to support the epilepsy community during the COVID-19 crisis. This funding will [...]
18th May 2020 We’re delighted to announce that our Scientific Director – Dr Wessel Woldman – has recently secured a prestigious Emerging Leader Fellowship from Epilepsy Research UK . Epilepsy Research UK [...]
27th April 2020 A paper published today in Scientific Reports documents the research underpinning Neuronostics’ technology. The R&D team in Neuronostics are building on these findings, which will enable diagnostic and prognostic [...]
22 April 2020 Building on the success of our first online discussion, where we welcomed over 50 participants to discuss the use of tech in managing epilepsy, we are pleased to confirm [...]
27 March 2020 Thanks to everyone that attended our first online forum yesterday on #purpleday! We hosted over 50 people from around the world, with representatives from Africa, America, Asia, Australia and [...]
25 March 2020 On Thursday 26th March, 3pm UK time (11am EDT), we'll host an online event discussing how technology can help support those living with epilepsy . During this period of [...]
In recognition of our research links with the Cornwall Partnership NHS Foundation Trust (CFT), Dr Leandro Junges has been invited to give a talk at the CFT's showcase event on 11 March [...]
On Thursday 6th February, we attended the Medlink South West Healthcare Innovation awards, where we were absolutely delighted to be awarded best new start up. Chaired by Professor Richard Luxton, and with [...]
Neuronostics is delighted to be nominated in the 'Start up' category for the Medilink South West awards to be held in Bristol on Thursday February 6th. The event itself offers an invaluable [...]
Professor John Terry (co-founder of Neuronostics and Professor at the University of Birmingham) has been invited to deliver a presentation at this year’s International League Against Epilepsy (ILAE) British Branch Annual Scientific [...]
18th December 2019 Neuronostics are excited to announce plans to establish a user-group to help shape its products and offerings. We are delighted to announce the first member of the group is Simon [...]
Wessel Woldman (our Scientific Director) delivered the opening lecture at the Birmingham Epilepsy Research Network meeting on Monday November 25th. The annual event, now in its 10th year, brings together clinicians, neurophysiologists, [...]
Neuronostics Ltd, today announces that it has been selected by Microsoft for a new programme designed to help startups get off the ground. Microsoft for Startups will provide up to $500 million worth of [...]